Detalhe da pesquisa
1.
N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2.
Cell
; 184(9): 2332-2347.e16, 2021 04 29.
Artigo
Inglês
| MEDLINE | ID: mdl-33761326
2.
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity.
Cell
; 184(5): 1171-1187.e20, 2021 03 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33621484
3.
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.
Cell
; 183(4): 1024-1042.e21, 2020 11 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32991844
4.
A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Nature
; 618(7965): 590-597, 2023 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-37258672
5.
Neutralization, effector function and immune imprinting of Omicron variants.
Nature
; 621(7979): 592-601, 2023 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-37648855
6.
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Nature
; 602(7898): 664-670, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35016195
7.
Broad sarbecovirus neutralization by a human monoclonal antibody.
Nature
; 597(7874): 103-108, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34280951
8.
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
Nature
; 597(7874): 97-102, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34261126
9.
Author Correction: A pan-influenza antibody inhibiting neuraminidase via receptor mimicry.
Nature
; 619(7970): E50, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37407829
10.
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
J Hepatol
; 79(5): 1129-1138, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37459920
11.
Orexin 2 receptor-selective agonist danavorexton (TAK-925) promotes wakefulness in non-human primates and healthy individuals.
J Sleep Res
; 32(5): e13878, 2023 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36934366
12.
The association between risk perceptions, anxiety, and self-reported changes in tobacco and nicotine product use due to COVID-19 in May-June 2020 in Israel.
BMC Public Health
; 23(1): 759, 2023 04 25.
Artigo
Inglês
| MEDLINE | ID: mdl-37098558
13.
Improving Knowledge, Engagement, and Self-Efficacy in the Creation of Healthy Home Environments for Mothers Using a Facebook Intervention (Design for Wellness): Randomized Controlled Trial.
J Med Internet Res
; 25: e46640, 2023 11 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37934566
14.
Development and validation of a new questionnaire to assess perceptions regarding DWELL: Design for WELLness.
Health Promot Int
; 38(3)2023 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37326407
15.
Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects.
Br J Clin Pharmacol
; 88(2): 600-612, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34240455
16.
Plain tobacco packaging: progress, challenges, learning and opportunities.
Tob Control
; 31(2): 263-271, 2022 03.
Artigo
Inglês
| MEDLINE | ID: mdl-35241599
17.
Efficient study design to estimate population means with multiple measurement instruments.
Stat Med
; 40(19): 4327-4340, 2021 08 30.
Artigo
Inglês
| MEDLINE | ID: mdl-34013642
18.
Safety, pharmacokinetics and pharmacodynamics of TAK-418, a novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A.
Br J Clin Pharmacol
; 87(12): 4756-4768, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33990969
19.
Beyond "Safe and Effective": The urgent need for high-impact smoking cessation medications.
Prev Med
; 150: 106567, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-33957153
20.
Protecting Children From Tobacco Smoke Exposure: A Randomized Controlled Trial of Project Zero Exposure.
Nicotine Tob Res
; 23(12): 2003-2012, 2021 11 05.
Artigo
Inglês
| MEDLINE | ID: mdl-34021353